Pfizer now anticipates its…
Pfizer now anticipates its Vyndamax sales to remain “relatively stable” [...]
Pfizer now anticipates its Vyndamax sales to remain “relatively stable” [...]
The FDA has told Amgen that it is proposing to withdraw [...]
Mundipharma and CorMedix have announced a win for their antifungal [...]
Eleventh-hour settlements with two of the three generic drugmakers involved [...]
Haleon, a healthcare consumer and OTC brand company, has hired [...]
The FDA rejected two new products from AbbVie and Grace [...]
After a series of setbacks for Sanofi’s tolebrutinib, the French [...]
An established sales force and payer authorization criteria will fuel [...]
Daiichi Sankyo has postponed its annual report by two weeks, [...]
Roche’s Genentech unit is launching a new multimedia campaign aimed [...]